You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Expressing humanized bacterial luciferase in stem cells: Moving beyond fireflyluciferase to expand the informational capacity of animal models for regenerativemedicine
SBC: 490 BIOTECH INC Topic: 400Expressing humanized bacterial luciferase in stem cellsMoving beyond firefly luciferase toexpand the informational capacity of animal models for regenerative medicine Project Summary This Small Business Technology TransferSTTRPhase II project proposes to develop complementary autonomously bioluminescentautobioluminescentin vitro stem cell lines and in vivo small animal model systems that enable th ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Advanced Assessment to Accelerate Diagnostic Skill Acquisition, Phase II
SBC: Parallel Consulting, LLC Topic: 300Project Summary Today s clinical learning environments do not provide the level of deliberate practicedirect supervisionand rigorous assessment and feedback needed to develop diagnostic reasoning expertiseClinical performance assessment emphasizes learner evaluation over learner developmentlacks rigor and utility for developmental purposesand clinical teachers have expressed particular difficulty ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Integrated tools for higher order structure determination by cross link analysis
SBC: PROTEIN METRICS INC Topic: 100Summary The use of mass spectrometry MS for quantitative protein characterization has increased dramatically identifying and quantifying thousands of proteins is no longer a heroic task nor is characterizing therapeutic proteins in detail Due to widely available software quantitative mass spectrometry has become routine and widely used for addressing questions in basic biology translational ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Integrated Platform for Mass Spectrometric Studies of Protein Structure
SBC: PROTEIN METRICS INC Topic: 100Summary Technology for studying the higher order structure HOS of biomolecules encompasses some of the most important tools in all of science and is a highlighted NIGMS research topic Mass spectrometric methods for studying HOS include oxidative footprinting and other methods to covalently label amino acid side chain functional groups and also hydrogen deuterium exchange HDX on protein bac ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers
SBC: PROTEIN METRICS INC Topic: 400Project SummaryGlycosylation is one of the most prevalent and important post translational modifications of proteinsyet it is also one of the most difficult to studyNo single method nor analytical platform can give complete information about the glycosylation in a protein sampleand the analytical methods in current use include both ESI and MALDI single and tandem mass spectrometryat least four typ ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Targeting STT3A and STT3B to Block Flavivirus Replication
SBC: New England Discovery Partners, LLC Topic: NIAIDAbstractMosquito borne flaviviruses cause disease worldwidewith members such as dengue virusDENVZika virusZIKVand west nile virusWNVinfecting more thanmillion individuals annuallyThe availability of small molecule antivirals that reduce flavivirus infection therefore could have an immediate and substantial impact on public health programs that seek to improve outcomes for populations infected with ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel System for Reducing Radiation Dose of CT Perfusion
SBC: Hura Imaging, Inc. Topic: 100Project Summary Abstract X ray computed tomography CT has been increasingly used in medical diagnosis currently reaching more than million CT scans every year in the US The increasing use of CT has sparked concern over the effects of radiation dose on patients It is estimated that every CT scans will cause one future cancer i e cases of future cancers from million CT scan ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
A Unified System for Wireless Optogenetics and Brain Microdialysis for Small Molecules Prototype Development and Validation
SBC: AMUZA, INC Topic: 101PROJECT SUMMARY While optogenetics is well suited for understanding the dynamic activity of neural circuits the first central theme of the NIH BRAIN Initiative PAR its neurochemical impacts remain largely uncharacterized due to a lack of appropriate tools Given that the predominant mode of cellular interactions is neurochemical commercial development of such tools will fulfill the ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Direct magnetic characterization of individual nanoparticles for optimized diagnostic imaging
SBC: ODMR Technologies, Inc Topic: 101Project Summary ODMR Technologies Inc and Prof Victor Acostaandapos s group at University of New Mexico UNM are developing a diamond chip platform capable of direct magnetic characterization of individual nanoparticles for optimized diagnostic imaging Our team is a spinoff from academic collaborations in the emerging field of diamond photonic sensors a field we helped create nearly a deca ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of the first-in-class novel dual PI-3K/BRD4 inhibitor SF2523
SBC: SignalRx Pharmaceuticals Inc. Topic: 102There is an unmet need to inhibit the key cancer promoting transcription factor MYCboth c MYC and MYCNthat act downstream of many cell receptors and signal transcription pathways to activate genes for cancer cell resistance and tumor growthTo datesmall molecule inhibitors of MYC have remained elusiveIn our Phase I STTRCAwe developed a lead compoundSFwhich displays potent orthogonal inhibitory acti ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health